Member Info for Argylerich

So does today's RNS makes yesterday's trading more likely to have been the result of an info leak spooking people.

Bones from advfn has a new moniker 😂

Reduced further to 0.85%. A little singed.

For those moaning about gas prices:

FOR IMMEDIATE RELEASE

July 9, 2024

EIA expects rising electricity demand and natural gas prices to affect electricity fuel mix for the rest of 2024

The U.S. Energy Information Administration (EIA) expects that the United States will generate more electricity from renewables and coal in the second half of this year, as electricity demand and natural gas prices increase. In its July Short-Term Energy Outlook (STEO), EIA forecasts that natural gas prices will be about 36% higher in the second half of the year than in the first half of the year, which the agency expects will lead to a decrease in electricity generation from natural gas—the largest fuel source for U.S. electricity.

🙈

Nope, in and holding.

Funny on here I'm being accused of forward selling and on advfn I'm pilloried for believing that a placing won't happen.

It doesn't pay to be pragmatic in this world LOL

Ant15 your comment re auditors is bang on.

The company basically has until the autumn (publishing of accounts early Nov) to prove to auditors that it's a going concern (cash, cash flow and order book) without needing additional funding .

If you own shares at the moment you basically believe they can achieve this on a risk/reward calculation against the current mcap.

Starting to concede defeat and reducing their short?

£2.1m in early Feb

£0.3m burn pcm x5 = £1.5m

Balance of £0.6m plus earnings from £0.55m orders processed should see them close to £1m with a filling order book.

Posted by Dr Tolley on Twitter.

https://www.clinicaltrialsarena.com/news/aptamer-optimer-astrazeneca-sirna-collaboration/?cf-view

Explains this is new business/offshoot from the work that's already progressing to licensing.

Panicing about your short Porky??

Harry, make of this what you will...

https://x.com/Greeninthewoods/status/1795836074545361194

The original drug from 2020 was imatinib which is made by Novartis,

Dr Tolley makes it quite clear that while they have something that can deliver imatinib, it is the not the drug in question.

It may not just be Unilever.

We've been promted a few times about the Liver related work they've been doing.

Have a look at this from 2020:

https://aptamergroup.com/aptamer-group-making-progress-in-2020/

Look at the section they refer to "Small molecule aptamers in press!"

They are discussing the use of their aptamers with imatinib, a liver chemo drug manufactured by Novartis.

Mozax, material is anything over 10% current turnover....

https://docs.londonstockexchange.com/sites/default/files/documents/AIM%20Rules%20for%20Companies%20%2801012021%29_1.pdf

We'll find out Tuesday afternoon 👍

Vii totally agree re the management having a strong stake.

Can they legally directly open to non "professionals" at this stage of the proceedings?

My mind on this is that it was always going to take a larger cash figure than the 25% limitation would bring from existing holders alone, so it's more a mistake that it was in there in the first place.

Personally I don't see too much of an issue with it as the co seem to be trying to include existing holders in the forthcoming raise (albeit limited to those with a piece of paper saying they're professional for now).

Great find Vii

Cornerstone investors get 1st dibs at the best prices LT. Just means they see long term value at these prices and have the capital to risk.

That's a large holding changing hands....